Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00902044
Title Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

sarcoma

osteosarcoma

Therapies

Fludarabine

Cyclophosphamide

HER2 sensitized T-cells

Age Groups: adult
Covered Countries USA


No variant requirements are available.